Search

everythinglearnresearchcommunity

for

Search:↓

Better hair loss models needed for research.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Finasteride helps hair growth but may cause sexual side effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.